Seizure disorder as a risk factor for gastroesophageal reflux in children with neurodevelopmental disabilities

John W Harrington1, Donald A Brand, Karen S Edwards

  • 1Department of Pediatrics, New York Medical College and Westchester Medical Center, 312 Munger Pavilion, Valhalla, NY 10595, USA.

Clinical Pediatrics
|July 13, 2004
PubMed

Insights

Children with neurodevelopmental disabilities undergoing gastrostomy tube placement face a higher risk of gastroesophageal reflux. Those with seizure disorders are four times more likely to need subsequent antireflux surgery.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Neurodevelopmental Disabilities

Background:

  • Gastroesophageal reflux (GER) development post-gastrostomy in children with severe neurodevelopmental disabilities is understudied.
  • Gastrostomy tubes are common interventions for feeding in this population.

Purpose of the Study:

  • To investigate the incidence of GER requiring intervention after gastrostomy placement in children with severe neurodevelopmental disabilities.
  • To identify risk factors associated with the development of GER post-gastrostomy.

Main Methods:

  • Retrospective review of medical records for 102 children who underwent gastrostomy between 1987 and 1997.
  • Analysis of neurologically related diagnoses, reflux diagnostic tests, and re-admission data within two years.
  • Comparison of outcomes between patients who received a gastrostomy tube alone versus those who had a simultaneous antireflux procedure.

Main Results:

  • Of 30 patients with follow-up data who received a gastrostomy tube alone, 7 (23%) required antireflux surgery within two years.
  • Children with a seizure disorder had a significantly higher risk (over 4-fold) of requiring re-admission for antireflux surgery compared to other patients (57% vs. 13%, P=0.03).

Conclusions:

  • A seizure disorder is a significant risk factor for developing symptomatic gastroesophageal reflux requiring surgical intervention after gastrostomy placement in children with severe neurodevelopmental disabilities.
  • This finding highlights the importance of considering concurrent antireflux procedures in neurologically impaired children with seizure disorders undergoing gastrostomy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...